Clinical Trial

Cerebellum and Autism: Regional Specialization for Social and Executive Functions

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 2, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this study is to determine the impact of neuromodulation to the cerebellum on social and executive functions in neurotypical young adults and young adults with autism.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-05-25; most recent amendment 2025-09-29.
Trial Details
NCT Number NCT05396352
Lead Sponsor American University
Collaborators: National Institutes of Health (NIH), National Institute of Mental Health (NIMH)
Conditions Autism, Autism Spectrum Disorder
Enrollment 80 participants
Start Date 2022-01-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-10-02